Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity

Details for Australian Patent Application No. 2006331637 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Reitz, Allen B.; Smith-Swintosky, Virginia L.

Agent Shelston IP

Pub. Number AU-A-2006331637

PCT Pub. Number WO2007/075833

Priority 60/751,499 19.12.05 US; 11/611,938 18.12.06 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/353 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075833 Priority application(s): WO2007/075833

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331638-Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy

2006331635-Lubricating oil with high oxidation stability